Proscia Apeature enables biopharmaceutical companies to accelerate precision drug development by delivering real-time patient insights from a global laboratory network on track to diagnose 8 million pathology cases annually. Opens new...

Dr. Lal PathLabs: It accurately detected single-cell and micrometastases that had been missed during manual reviews. Results were later validated through IHC, confirming the system’s reliability Dr. Lal PathLabs (DLPL) has adopted a deep...

Paige: Oncoclínicas&Co Utilizes Paige’s AI-Assisted Diagnostic Applications to Enhance Diagnostic Capabilities and Further Support Patient Safety NEW YORK & SÃO PAULO--(BUSINESS WIRE)--Paige, a leader in...

Roche: Information platform empowers the public with knowledge on latest cancer treatment technologies According to data from the Hong Kong Cancer Registry of the Hospital Authority, the overall five-year survival rate for cancer patients has...

Albuquerque, NM, April 30, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and...

The Roche VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment.  The device uses artificial intelligence-based image analysis with a...